Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease... see more

TSX:SZLS - Post Discussion

View:
Post by brad129 on Jan 26, 2022 1:05pm

Burn rate

Anyone have an idea of their burn rate since acquiring Care and an estimate with all the new hires? It use to be about 300k a month, I am sure it's substantially higher now.
Comment by IainCaimbeul on Jan 26, 2022 4:14pm
Ask gojo, he knows everything.
Comment by brad129 on Jan 26, 2022 9:03pm
Best I can figure with the last quarter results is it cost them all in about 3 million for the quarter that's a million a month (I'm sick of hearing re-evaluate warrants) that was really without having to pay Care doctors and staff, with that said no revenue from Care either. But since then we have had alot of Job posting so I figuring in 1.3-1.5 per month just to break even. Financing is ...more  
Comment by LithLover on Jan 26, 2022 9:28pm
Makes you wonder if HC is shorting it to keep it down for a low PP.  Stage has $1.59 million cash plus financing to get them about $6 million plus revenues since Sept  I think we good for a few quarters.   If they could get the SP up than warrants would be exercised for more cash.  But you are right will revenue rise and share price rise for warrant execution before cash burn ...more  
Comment by Liked2Think on Jan 26, 2022 10:04pm
Ha always with the mystery secret agenda.  Everyone wants a low PP. jesus how much lower do they want to kick this pig down? if so many big companies have so much faith in this stock then whats the big deal from paying at 25 cents vs 30 cents.  I mean its going to the moon aint it!
Comment by brad129 on Jan 26, 2022 10:44pm
well we heard (not sure where) Care was doing about 1 million a quarter prior to we acquired them, so that leaves us about a million a month required, we don't need to see anywhere near break even to have upward movement but we sure as hell need far more than the 600k revenue last quarter( above the 1million Care should bring) we have Covid testing and Aristotle being pushed so let's see ...more  
Comment by Liked2Think on Jan 26, 2022 11:43pm
you dont have CARE doing 1M a quarter. You have Tripp saying that CARE does 1M a quarter we all know how much Tripp's word is worth.
Comment by Liked2Think on Jan 26, 2022 10:01pm
so they only need to do 33 aristotle tests every working day of the month to break even then! ha they will float stock again right after another meaningless "hub" news release.  you will see the same manipulation of the share price again just like last time.  I bet they only get 34 cents a share this time though.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities